标题/作者	年份
Coronavirus biology and replication: implications for SARS-CoV-2 P V’kovski, A Kratzel, S Steiner, H Stalder, V Thiel Nature Reviews Microbiology 19 (3), 155-170	2021
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19 DR Owen, CMN Allerton, AS Anderson, L Aschenbrenner, M Avery, ... Science 374 (6575), 1586-1593	2021
RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences SK Burley, C Bhikadiya, C Bi, S Bittrich, L Chen, GV Crichlow, CH Christie, ... Nucleic acids research 49 (D1), D437-D451	2021
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity D Shin, R Mukherjee, D Grewe, D Bojkova, K Baek, A Bhattacharya, ... Nature 587 (7835), 657-662	2020
SARS-CoV-2: structure, biology, and structure-based therapeutics development MY Wang, R Zhao, LJ Gao, XF Gao, DP Wang, JM Cao Frontiers in cellular and infection microbiology 10, 587269	2020
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model BR Beck, B Shin, Y Choi, S Park, K Kang Computational and structural biotechnology journal 18, 784-790	2020
Effect of coronavirus disease 2019 (COVID‐19) on maternal, perinatal and neonatal outcome: systematic review J Juan, MM Gil, Z Rong, Y Zhang, H Yang, LC Poon Ultrasound in Obstetrics & Gynecology 56 (1), 15-27	2020
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease C Ma, MD Sacco, B Hurst, JA Townsend, Y Hu, T Szeto, X Zhang, ... Cell research 30 (8), 678-692	2020
Maternal death due to COVID-19 S Hantoushzadeh, AA Shamshirsaz, A Aleyasin, MD Seferovic, SK Aski, ... American journal of obstetrics and gynecology 223 (1), 109. e1-109. e16	2020
Candidate drugs against SARS-CoV-2 and COVID-19 DL McKee, A Sternberg, U Stange, S Laufer, C Naujokat Pharmacological research 157, 104859	2020
The SARS-CoV-2 main protease as drug target S Ullrich, C Nitsche Bioorganic & medicinal chemistry letters 30 (17), 127377	2020
Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates YW Chen, CPB Yiu, KY Wong F1000Research 9	2020
COVID-19: Discovery, diagnostics and drug development T Asselah, D Durantel, E Pasmant, G Lau, RF Schinazi Journal of hepatology 74 (1), 168-184	2021
An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study S Das, S Sarmah, S Lyndem, A Singha Roy Journal of Biomolecular Structure and Dynamics 39 (9), 3347-3357	2021
Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach SK Enmozhi, K Raja, I Sebastine, J Joseph Journal of Biomolecular Structure and Dynamics 39 (9), 3092-3098	2021
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease A Douangamath, D Fearon, P Gehrtz, T Krojer, P Lukacik, CD Owen, ... Nature communications 11 (1), 5047	2020
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur Z Jin, Y Zhao, Y Sun, B Zhang, H Wang, Y Wu, Y Zhu, C Zhu, T Hu, X Du, ... Nature structural & molecular biology 27 (6), 529-532	2020
COVID-19: drug targets and potential treatments C Gil, T Ginex, I Maestro, V Nozal, L Barrado-Gil, MÁ Cuesta-Geijo, ... Journal of medicinal chemistry 63 (21), 12359-12386	2020
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication W Vuong, MB Khan, C Fischer, E Arutyunova, T Lamer, J Shields, ... Nature communications 11 (1), 4282	2020
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease L Fu, F Ye, Y Feng, F Yu, Q Wang, Y Wu, C Zhao, H Sun, B Huang, P Niu, ... Nature communications 11 (1), 4417	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。